Industry News

      Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

      WILMINGTON, Del.--(BUSINESS WIRE)--Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit...

      IDRx Presents Preliminary Clinical Data from Ongoing Phase 1 StrateGIST Study at CTOS 2023 Supporting Best-in-Class Potential of IDRX-42 in Patients with GIST

      PLYMOUTH, Mass.--(BUSINESS WIRE)--IDRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment with purpose-built precision therapies, today announced preliminary clinical...

      Arrowhead Pharmaceuticals to Present New Phase 2 Clinical Data on Cardiometabolic Pipeline at AHA 2023

      PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will present new Phase 2 clinical data from the...

      Teva to Present New Data Supporting Safety, Efficacy and Real-World Effectiveness of AUSTEDO® (deutetrabenazine) Tablets at the 2023 HSG Annual Meeting

      TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today...

      GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

      CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies...

      Pioneering Phase III Clinical Trial Investigates Multiple Potential Long-COVID Treatments

      VANCOUVER, British Columbia--(BUSINESS WIRE)--Prominent contract research organization, Purpose Life Sciences (PLS) is set to launch a groundbreaking Phase III clinical trial...

      Recent Articles